Synchron 40M Khosla Ventures Park FierceBiotech

Synchron 40M Khosla Ventures Park FierceBiotech

Company: Synchron 

Fund Raised: $40 million

Investor: Khosla Ventures with Bionaut Labs, Docbot, Flow Neuroscience

CEO: Thomas Oxley 

Future Plans: After years of research Synchron officially brings buzz to MedTech. Synchron with Bionaut Labs, Docbot, and other neurosurgeons bring non-AI tech for paralyzed patients that help them to order, shop, text, and email just by thinking.

Thomas Oxley, CEO of Synchron said that we raise $40 million to hire experts and upgrade equipment. We will restore communication for paralyzed patients with smartphones. Moreover, we bring the revolution by setting up the electric brain setup without surgery.

Also, read PortalOne $15M Atari Founders Fund Kevin Lin

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *